NOCD Raises $34 Million In Investment Round Led By Cigna Ventures & 7wireVentures

NOCD, which provides specialty treatment for obsessive compulsive-disorder (OCD), raised $34 million in investment round co-led by Cigna Ventures and 7wireVentures. The company plans to use the funding to expand its network of specialists. The round included participation from new investor Longitude Capital as well as other existing investors Kaiser Permanente Ventures, F-Prime Capital, Eight Roads Capital, and Health Enterprise Partners.

Since the business was launched in 2018, NOCD has expanded to provide care in all 50 states and internationally. It delivers more than 250,000 therapy sessions each year. Its therapeutic approach reduces OCD symptom severity . . .